Print
Text Size
Pro-Stride® APS
Pro-Stride® APS is a device that creates a solution to manage equine lameness and osteoarthritis in horses by concentrating the cells, platelets, growth factors and anti-inflammatory cytokines from a horse’s own blood.
Overview
Pro-Stride APS is primarily used in helping manage osteoarthritis in horses and other causes of lameness to help reduce pain and inflammation.1 The < 20-minute process uses the horse’s own blood to create a concentrated solution that amplifies the healing process when injected into the joint.1
Pro-Stride can serve as a natural alternative to conventional osteoarthritis management options. The resulting concentrated solution of cells, platelets, growth factors and anti-inflammatory cytokines helps relieve pain, and restore the balance of inflammatory and anti-inflammatory cytokines within the joint.1
Collapse All
-
Pro-Stride® APS is fast, convenient and easy to use to help manage horse lameness and osteoarthritis.
Key clinical uses of Pro-Stride® APS include osteoarthritis, synovitis, tendon injuries.
Safe for the horse2
- Natural and autologous (made up of cells from horse’s own body)
- High concentration of anti-inflammatory proteins (including IRAP, IL-1ra, A2M, sIL-1R and sTNF-R's)1, 3
- Proven effectiveness2
- Clinically demonstrated2
- Able to manage a wide range of key clinical issues
Convenient for you
- Stall side
- Portable
- Fast processing in less than 20 minutes
- No incubation required
- Never frozen
-
Download easy-to-follow instructions that will take you step-by-step through how to process the Pro-Stride® APS device.
Download instructions
References
- Linardi RL, Dodson ME, Moss KL et al. The Effect of Autologous Protein Solution on the Inflammatory Cascade in Stimulated Equine Chondrocytes. Frontiers in Veterinary Science. 06 March 2019. Volume 6, article 64, Pages 1–9.
- Bertone AL, Ishihara A, Zekas L et al. Evaluation of a Single Intra-articular Injection of Autologous Protein Solution for Treatment of Osteoarthritis in Horses. AJVR Vol 75, No. 2, February 2014. 141-151.
- Muir, S. M., Reisbig, N., Baria, M., Kaeding, C., & Bertone, A. L. (2019). The concentration of plasma provides additional bioactive proteins in platelet and autologous protein solutions. The American Journal of Sports Medicine, 47(8), 1955–1963. https://doi.org/10.1177/0363546519849671
Alpha2EQ is a registered trademark of Astaria Global, LLC.
PRS-00062A
United States 
